HIVの迅速診断技術を開発:数分で結果が得られる新検査法(New HIV test delivers accurate results in minutes)

ad

2025-04-02 ノースウェスタン大学

HIVの迅速診断技術を開発:数分で結果が得られる新検査法(New HIV test delivers accurate results in minutes)Northwestern scientists have developed a new technology that can detect multiple HIV antigens at high sensitivity in a matter of minutes.

ノースウェスタン大学の研究チームは、HIV感染を数分で高感度に検出できる新しい技術を開発しました。この技術は、ナノメカニカルプラットフォームと微小なカンチレバーを利用し、複数のHIV抗原を迅速に検出します。従来のHIV診断法は、感染後数週間で形成されるHIV特異的抗体の検出に依存しており、早期発見が難しいという課題がありました。新しい検査法では、HIV抗体とp24抗原(より早期のHIV感染マーカー)の両方を検出し、臨床検査室を必要とせず、迅速な診断が可能となります。この技術は、太陽光発電デバイスに組み込むことで、早期発見が課題となっている地域でも活用でき、脆弱な集団への迅速な介入が期待されます。

<関連情報>

HIV-1 p24抗原の迅速検出のためのナノ機械システム Nanomechanical systems for the rapid detection of HIV-1 p24 antigen

Angel Green Samuel, Daphne Cornish, Lacy M. Simons, Dilip Agarwal, Gajendra S. Shekhawat, Judd F. Hultquist, Vinayak P. Dravid
Biosensors and Bioelectronics  Available online: 22 March 2025
DOI:https://doi.org/10.1016/j.bios.2025.117395

Abstract

Early detection of HIV is crucial for reducing transmission and ensuring timely initiation of antiretroviral therapy (ART), significantly improving patient outcomes. Although diagnostic tests have advanced from first-generation antibody detection assays to fourth-generation immunoassays that detect both HIV antibodies and the p24 antigen, these are limited to clinical labs. Their longer processing times, high costs, and the requirement for multiple patient visits highlight the need for rapid, affordable point-of-care (POC) diagnostics. This study introduces a nanomechanical cantilever-based biosensor for the rapid detection of HIV-1 p24 antigen, a key marker for early diagnosis. The platform demonstrated remarkable sensitivity, detecting p24 at concentrations as low as 100 fg/mL in solution and 1 pg/mL in human serum, and was quantitative within several orders of magnitude. After functionalizing the microcantilevers with two broadly cross-reactive monoclonal antibodies (ANT-152 and C65690M), the system was able to detect p24 from a wide range of HIV-1 subtypes. Furthermore, this biosensor was found to be compatible with various blood processing methods and with a direct electronic output. This platform’s high sensitivity, specificity, and applicability across multiple HIV subtypes underscores its potential for future development into a next-generation POC diagnostic tool.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました